blue connect dots

Tag: prior authorization

blue connect dots

January 16, 2024

Generative AI for Healthcare: Helper or Hindrance in Automated Prior Authorizations?

by Susan Lawson-Dawson | Healthcare Technology, Prior Authorization

It only took ChatGPT five days to surpass 1 million users. Two months later, the generative AI application boasted an impressive 100 million active monthly users, and that figure keeps climbing. Is it any wonder that the healthcare industry has been buzzing about the potential of generative AI?  Where is the potential greatest?  An August 2023 AMA Survey found that physicians are most enthusiastic about leveraging AI tools to reduce administrative burdens, such as automating prior authorizations. That fits with expert assessments as well. Forbes reported last fall that, “According to a McKinsey analysis, AI-enabled prior authorizations can automate up… Read entire article here

August 15, 2023

Myndshft & Shadowbox Collaboration Targets Ancillary Service Providers’ Prior Authorization Pain Points

by Susan Lawson-Dawson | Healthcare Technology, Prior Authorization

Navigating our healthcare landscape often feels like wading through a sea of administrative hurdles—with prior authorizations recognized as one of the most frustrating. For ancillary service providers like diagnostic labs, it can feel like the prior authorization bar is set even higher.  Our newly announced collaboration with Shadowbox bridges crucial gaps. Together, Shadowbox instant healthcare automation enables fast integration of Myndshft prior authorization software and facilitates data sharing across different web applications and data silos. This streamlines the prior authorization process within established workflows you  rely on. Our combined solution signifies an evolution in process efficiency but also addresses the… Read entire article here

April 25, 2023

Navigating Biomarker Obstacles: The Role of Prior Authorization Software in Personalized Cancer Therapy

by Susan Lawson-Dawson | Healthcare Technology, Prior Authorization

Between 2000 and 2018, the use of biomarkers in oncology clinical trials grew from 15% to 55%, for good reason. The use of biomarkers in cancer care enables personalized treatment options, revolutionizing the way oncologists diagnose and treat cancer patients. Biomarkers can help identify the most effective therapies for individual patients. Despite the proven benefits of biomarker testing, however, many cancer patients still face barriers to accessing this essential tool due to prior authorization. By automating the prior authorization process, oncologists can expedite personalized cancer care, increasing the chances of successful outcomes and reducing unnecessary treatments.  Prior authorization creates roadblocks… Read entire article here

April 18, 2023

News Flash: Myndshft Prior Authorization Software Part of Newly Launched Google Cloud Claims Acceleration Suite

by Susan Lawson-Dawson | News

As the Healthcare Information and Management Systems Society (HIMSS) 2023 Global Health Conference & Exhibition kicked off yesterday, Myndshft announced a collaborative solution with Google Cloud to streamline prior authorization submission and status monitoring. End-to-end prior authorization automation The new Google Cloud Claims Acceleration Suite leverages Myndshft to enable quick and seamless submission of prior authorization requests. Myndshft supports near real-time benefits verification, including an accurate calculation of out-of-pocket costs using healthcare providers’ contracted rates and patients’ exact benefits; pre-check of prior authorization requests for errors, missing information, and medical necessity; submission through the health plan’s preferred submission path; and… Read entire article here